September 19, 2021
Company Info
| Industry | Food Distributors |
|---|---|
| Sector | Distribution Services |
| Employees | 58,000 |
| CEO | Mr. Kevin P. Hourican |
| Address | 1390 Enclave Parkway , Houston, TX 77077-2099 |
|---|---|
| Phone | 1.281.584.1390 |
| Website | www.sysco.com |
Sysco Corp. engages in selling, marketing, and distribution of food products to restaurants, healthcare and educational facilities, and lodging establishments. It operates through the following segments: U.S. Foodservice Operations, International Foodservice Operations, SYGMA, and Other. The U.S. Foodservice Operations consists of U.S. Broadline operations, custom-cut meat and seafood companies, FreshPoint, and European Imports. The International Foodservice Operations segment includes broadline operations in America and Europe, which distribute a full line of food products and a wide variety of non-food products. The SYGMA segment represents its customized distribution subsidiary. The Other segment covers hotel supply operations. The company was founded by John F. Baugh in 1969 and is headquartered in Houston, TX.
Competitors
| Company Name | 3 Month %Change |
1 Year %Change |
|---|---|---|
| Sysco Corp. | 0.07% | 11.24% |
| McKesson Corp. | 9.69% | 37.13% |
| Ferguson Plc | 5.24% | 46.27% |
| Fastenal Co. | 5.29% | 19.66% |
| AmerisourceBergen Corp. | 4.54% | 27.54% |
Statement Summary
as of 4:10 ET PM 09/16/2021| Total Assets (MRQ) | 21.4 B |
|---|---|
| Total Liabilities (MRQ) | 19.8 B |
| Shareholders’ Equity (MRQ) | 1.6 B |
| Total Revenue (Annual) | 16.1 B |
| Net Income (Annual) | 151.1 M |
Earnings And Estimates
as of 4:10 ET PM 09/16/2021
| Current Qtr EPS Estimate | 0.88 |
|---|---|
| Current FY EPS Estimate | 3.57 |
| Long Term EPS Growth Estimate | 0.00 |
| Next Expected Earnings Date | 11/8/2021 |
SYY vs S&P 500
as of 09/16/2021| Relative To S&P 500 |
SYY | |
|---|---|---|
| 4 Weeks | n/a | n/a |
| 12 Weeks | n/a | n/a |
| YTD | n/a | n/a |
Earnings Surprises
as of 4:10 ET PM 09/16/2021| Fiscal Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 06/2021 | 0.61 | 0.71 | +15.99% |
| 03/2021 | 0.20 | 0.22 | +12.11% |
| 12/2020 | 0.34 | 0.17 | -49.88% |
| 09/2020 | 0.25 | 0.34 | +38.01% |
| 06/2020 | -0.30 | -0.29 | -2.93% |
| 03/2020 | 0.58 | 0.45 | -23.00% |
| 12/2019 | 0.83 | 0.85 | +1.83% |
| 09/2019 | 0.97 | 0.98 | +1.37% |
Financial Strength
as of 4:10 ET PM 09/16/2021| Pre-Tax Margin | 0.88 |
|---|---|
| Net Margin | 0.00 |
| Operating Margin | 3.84 |
| Return On Equity | 38.67 |
| Return On Assets | 2.38 |
| Inventory Turnover (TTM) | 12.35 |
| Sales Growth (MRQ) | 0.37 |
Ratios
as of 4:10 PM ET 09/16/2021| Price/Earnings (TTM) | 74.72 |
|---|---|
| Price/Book (MRQ) | 25.06 |
| Price/Cash Flow (TTM) | 19.10 |
| Book Value (MRQ) | 3.04 |
| Quick Ratio (MRQ) | 0.96 |
| Current Ratio (MRQ) | 1.47 |
| Total Debt/Equity (MRQ) | 7.61 |
Short Interest
as of 4:10 PM ET 09/17/2021| % Short - 1.78% | |
| % Remaining Float - 98.22% |
| Current | Last Month | |
|---|---|---|
| Short Interest Date | 08/31/2021 | 08/13/2021 |
| Short Interest Shares | 9,072,883 | 8,259,944 |
| Short Interest Ratio | 4.3 | 3.3 |
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00
0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00
0,0.00
Cash from
Activities
0,0.00
0,0.00
Cash from
Fin. Activities
0,0.00
0,0.00
TOTAL ASSETS |
TOTAL LIABILITIES |
TOTAL EQUITY |
|---|---|---|
Balance Sheet
| M Y | ||||
|---|---|---|---|---|
| ASSETS | ||||
| Cash And Equivalents | 0,0.00 | |||
| Receivables | 0,0.00 | |||
| Inventories | 0,0.00 | |||
| Other Current Assets | 0,0.00 | |||
| Total Current Assets | 0,0.00 | |||
| Property, Plant & Equipment, Gross | 0,0.00 | |||
| Accumulated Depreciation & Depletion | 0,0.00 | |||
| Property, Plant & Equipment, Net | 0,0.00 | |||
| Intangibles | 0,0.00 | |||
| Other Non-Current Assets | 0,0.00 | |||
| Total Non-Current Assets | 0,0.00 | |||
| TOTAL ASSETS | 0,0.00 | |||
| Liabilities & Shareholder Equity | ||||
| Accounts Payable | 0,0.00 | |||
| Short Term Debt | 0,0.00 | |||
| Total Current Liabilities | 0,0.00 | |||
| Long Term Debt | 0,0.00 | |||
| Deferred Income Taxes | 0,0.00 | |||
| Other Non-Current Liabilities | 0,0.00 | |||
| Minority Interest | 0,0.00 | |||
| Total Non-Current Liabilities | 0,0.00 | |||
| Preferred Stock Equity | 0,0.00 | |||
| Common Stock Equity | 0,0.00 | |||
| Common Par | 0,0.00 | |||
| Additional Paid In Capital | 0,0.00 | |||
| Cumulative Translation Adjustment | 0,0.00 | |||
| Retained Earnings | 0,0.00 | |||
| Treasury Stock | 0,0.00 | |||
| Other Equity Adjustments | 0,0.00 | |||
| Total Capitalization | 0,0.00 | |||
| TOTAL EQUITY | 0,0.00 | |||
| TOTAL LIABILITIES & STOCK EQUITY | 0,0.00 | |||
| Total Common Shares Outstanding | 0,0.00 | |||
| Preferred Shares | 0,0.00 | |||
| Treasury Shares | 0,0.00 | |||
| Basic Weighted Shares Outstanding | 0,0.00 | |||
| Diluted Weighted Shares Outstanding | 0,0.00 | |||
| Number Of Employees | 0,0.00 | |||
| Number Of Part-Time Employees | 0,0.00 | |||
TOTAL REVENUES |
EBT Excluding Unusual Items |
NET INCOME |
|---|---|---|
Income Statement
| M Y | |
|---|---|
| Sales | 0,0.00 |
| Cost Of Sales | 0,0.00 |
| Gross Operating Profit | 0,0.00 |
| Selling, General, And Administrative Expenses | 0,0.00 |
| Research & Development | 0,0.00 |
| Operating Income Before D & A (EBITDA) | 0,0.00 |
| Depreciation & Amortization | 0,0.00 |
| Interest Income | 0,0.00 |
| Other Income - Net | 0,0.00 |
| Special Income / Charges | 0,0.00 |
| Total Income Before Interest Expenses (EBIT) | 0,0.00 |
| Interest Expense | 0,0.00 |
| Pre-Tax Income | 0,0.00 |
| Income Taxes | 0,0.00 |
| Minority Interest | 0,0.00 |
| Net Income From Continuing Operations | 0,0.00 |
| Net Income From Discontinued Operations | 0,0.00 |
| Net Income From Total Operations | 0,0.00 |
| Extraordinary Income/Losses | 0,0.00 |
| Income From Cum. Effect Of Acct. Change | 0,0.00 |
| Income From Tax Loss Carryforward | 0,0.00 |
| Other Gains / Losses | 0,0.00 |
| Total Net Income | 0,0.00 |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0,0.00 |
| Preferred Dividends | 0,0.00 |
| Net Income Available To Common | 0,0.00 |
| Basic EPS From Continuing Ops. | 0,0.00 |
| Basic EPS From Discontinued Ops. | 0,0.00 |
| Basic EPS From Total Operations | 0,0.00 |
| Basic EPS From Extraordinary Inc. | 0,0.00 |
| Basic EPS From Cum Effect Of Accounting Change | 0,0.00 |
| Basic EPS From Tax Loss Carryf'd. | 0,0.00 |
| Basic EPS From Other Gains (Losses) | 0,0.00 |
| Basic EPS, Total | 0,0.00 |
| Basic Normalized Net Income/Share | 0,0.00 |
| EPS From Continuing Ops. | 0,0.00 |
| EPS From Discontinued Ops | 0,0.00 |
| EPS From Total Ops. | 0,0.00 |
| EPS From Extraord. Inc. | 0,0.00 |
| EPS From Cum Effect of Accounting Change | 0,0.00 |
| EPS From Tax Loss Carfd. | 0,0.00 |
| EPS From Other Gains (L) | 0,0.00 |
| EPS, Total | 0,0.00 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0,0.00 |
| Dividends Paid Per Share | 0,0.00 |
CASH FROM OPERATIONS |
CASH FROM INVESTING ACTIVITIES |
CASH FROM FINANCING ACTIVITIES |
|---|---|---|
Cash Flow Statement
| M Y | ||||
|---|---|---|---|---|
| Cash Flow From Operating Activities | ||||
| Net Income (Loss) | 0,0.00 | |||
| Operating Gains/Losses | 0,0.00 | |||
| Gross Operating Profit | 0,0.00 | |||
| (Increase) Decrease In Receivables | 0,0.00 | |||
| (Increase) Decrease In Inventories | 0,0.00 | |||
| (Increase) Decrease In Other Current Assets | 0,0.00 | |||
| (Decrease) Increase In Other Current Liabilities | 0,0.00 | |||
| (Increase) Decrease In Other Working Capital | 0,0.00 | |||
| Other Non-Cash Items | 0,0.00 | |||
| Net Cash From Continuing Operations | 0,0.00 | |||
| Net Cash From Discontinued Operations | 0,0.00 | |||
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 0,0.00 | |||
| Sale Of Property, Plant & Equipment | 0,0.00 | |||
| Cash Used For Investing Activities | ||||
| Sale Of Short-Term Investments | 0,0.00 | |||
| Purchases Of Property, Plant & Equipment | 0,0.00 | |||
| Acquisitions | 0,0.00 | |||
| Purchases Of Short-Term Investments | 0,0.00 | |||
| Other Cash From Investing Activities | 0,0.00 | |||
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 0,0.00 | |||
| Issuance Of Debt | 0,0.00 | |||
| Cash Used For Financing Activities | ||||
| Issuance Of Capital Stock | 0,0.00 | |||
| Repayment Of Long-Term Debt | 0,0.00 | |||
| Repurchase Of Capital Stock | 0,0.00 | |||
| Payment Of Cash Dividends | 0,0.00 | |||
| Other Financing Charges, Net | 0,0.00 | |||
| Net Cash From Financing Activities | 0,0.00 | |||
| Effect Of Exchange Rate Changes | 0,0.00 | |||
| Net Change In Cash & Cash Equivalents | 0,0.00 | |||
Earnings Estimates
as of 4:10 ET PM 09/16/2021| Current Qtr (09/2021) |
Next Qtr (12/2021) |
|
|---|---|---|
| Consensus Estimate | $0.88 | $0.79 |
| # of Estimates | 12 | 12 |
| High Estimate | $1.01 | $0.84 |
| Low Estimate | $0.70 | $0.70 |
| Year Ago EPS | $0.43 | $0.13 |
| Year Over Year Growth Estimate | 106.19% | 501.30% |
| Current Yr (06/2022) |
Next Yr (06/2023) |
|
|---|---|---|
| Consensus Estimate | $3.57 | $4.30 |
| # of Estimates | 14 | 13 |
| High Estimate | $4.24 | $5.10 |
| Low Estimate | $3.31 | $3.85 |
| Year Ago EPS | $1.44 | $3.57 |
| Year Over Year Growth Estimate | 148.12% | 20.35% |
| Current Qtr (09/2021) |
Next Qtr (12/2021) |
Current Year (06/2022) |
Next Year (06/2023) |
|
|---|---|---|---|---|
| Consensus Estimate | $0.88 | $0.79 | $3.57 | $4.30 |
| # of Estimates | 12 | 12 | 14 | 13 |
| High Estimate | $1.01 | $0.84 | $4.24 | $5.10 |
| Low Estimate | $0.70 | $0.70 | $3.31 | $3.85 |
| Year Ago EPS | $0.43 | $0.13 | $1.44 | $3.57 |
| Year Over Year Growth Estimate | 106.19% | 501.30% | 148.12% | 20.35% |
Insider Information Summary
as of 08/31/2021| % Insiders - 0.33% | |
| % Remaining Total Shares - 99.67% |
| Current | 1 Month | |
|---|---|---|
| Net Insider Transaction | -2.85 M | -5.46 M |
| Shares Bought | 73.09 K | 1.55 K |
| Shares Sold | 2.92 M | 5.46 M |
Insider Activity
| Transaction Date | Insider/Title | Transaction Type | Market Value | Shares | Average Price | Current Holdings | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
LATEST NEWS
Latest News
Cramer's Mad Money Recap: Speculation, COVID, Meme Stocks
- Jul 19, 2021 10:51 PM EDT
Mad Money Lightning Round: Chevron, Nokia, Pioneer Natural Resources
- May 22, 2021 7:30 AM EDT
Cramer's Mad Money Recap: Lordstown Motors, Intuit, Costco
- May 21, 2021 8:23 PM EDT
Sysco Announces New 2025 Seafood Sustainability Commitments
- Jan 14, 2021 8:00 AM EST
Sysco Names Aaron E. Alt Chief Financial Officer
- Nov 17, 2020 8:00 AM EST
Mad Money Recap With Jim Cramer: Prepare For a Long Winter
- Nov 14, 2020 12:04 PM EST
Sysco Announces 2020 Corporate Social Responsibility Report
- Oct 28, 2020 8:00 AM EDT
Recent Articles from TheStreet
Jensen: These Three Healthcare Stocks Are Worth a Look
Just because we're in the market's worst month of the year doesn't mean there aren't good investments available.
Parus Files Second Patent Infringement Lawsuit Against Apple
Parus files a second patent infringement lawsuit against Apple, alleging it infringed on its patents for voice-browsing and device control technology.
Business Software Provider AvidXchange Files for IPO
Accounts payable software provider AvidXchange on Friday filed for a initial public offering.
Intraday Reversals Signal Struggles for Market
But James "Rev Shark" Deporre says the trading action is both normal, and appropriate for September, and he's been adding some names to his portfolio.
Cramer's Mad Money Recap: FedEx, Costco, Nike
Jim Cramer says this is a rough season for stock, and investors need to take defensive action.
Jensen: Economy Has a Bearish Outlook
Real Money's Bret Jensen says a slower-than-expected pandemic recovery is a warning for the stock market.
FDA Panel Recommends Covid Booster Shots for 65, Older and Those at High Risk
Food and Drug Administration's advisory panel on Friday voted to recommend Covid-19 booster shots of the Pfizer vaccine for a limited section of the population.
Stock Market Today With Jim Cramer: How to Trade Ford
Jim Cramer discusses Ford and the impact of the impending tax policy changes on the stock market.
CLOSE
CLOSE
CLOSE
CLOSE